Pressebereich

Actions

160503 PR US CRM Iperia HF-T FDA Approval EN

Actions

Iperia HF-T Completes BIOTRONIK’s US Portfolio of MR Conditional Tachycardia Devices

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators






Please contact us if you require further information

${loading}